[ Back ]

Ensem Therapeutics

ensemtx.com
880 Winter St, Suite 1003
Waltham, MA 2451

Company Info

Year Established
2021

Contacts

Shengfang Jin, Ph.D.
President & CEO

X. Joanna Wu
General Counsel

Company Description

ENSEM leverages its unique Kinetic Ensembleﾮ platform to develop innovative small molecule precision medicines for oncology.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.